Abstract
Traumatic rupture of the descending thoracic aorta remains a leading cause of death following major blunt trauma. Management has evolved from uniformly performing emergent open repair with clamp and sew technique to include open repair with mechanical circulatory support, medical management and most recently, endovascular repair. This latter approach appears, in the short term, to be associated with perhaps better outcome, but long term data is still accruing. While an attractive option, there are specific anatomic and physiologic factors to be considered in each individual case.
Keywords: Traumatic rupture, thoracic aorta, endovascular, stent-graft
Current Cardiology Reviews
Title: Current Management of Traumatic Rupture of the Descending Thoracic Aorta
Volume: 5 Issue: 3
Author(s): Riyad Karmy-Jones, Nichole Jackson, William Long and Alan Simeone
Affiliation:
Keywords: Traumatic rupture, thoracic aorta, endovascular, stent-graft
Abstract: Traumatic rupture of the descending thoracic aorta remains a leading cause of death following major blunt trauma. Management has evolved from uniformly performing emergent open repair with clamp and sew technique to include open repair with mechanical circulatory support, medical management and most recently, endovascular repair. This latter approach appears, in the short term, to be associated with perhaps better outcome, but long term data is still accruing. While an attractive option, there are specific anatomic and physiologic factors to be considered in each individual case.
Export Options
About this article
Cite this article as:
Karmy-Jones Riyad, Jackson Nichole, Long William and Simeone Alan, Current Management of Traumatic Rupture of the Descending Thoracic Aorta, Current Cardiology Reviews 2009; 5 (3) . https://dx.doi.org/10.2174/157340309788970324
DOI https://dx.doi.org/10.2174/157340309788970324 |
Print ISSN 1573-403X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6557 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Jean-Baptiste de Sénac’s (1693-1770) Important Work on Cardiology and Valvular Disorders
Current Pharmaceutical Design Inflammation in Ischemic Stroke Subtypes
Current Pharmaceutical Design Hyperhomocysteinemia and Cardiovascular Risk: Effect of Vitamin Supplementation in Risk Reduction
Current Clinical Pharmacology Review of the Biological Activity of Maslinic Acid
Current Drug Targets Nitric Oxide Releasing Nanomaterials for Cancer Treatment: Current Status and Perspectives
Current Topics in Medicinal Chemistry Real-Time 3D Echocardiography: A New Gold Standard for Rheumatic Mitral Stenosis Assessment
Current Cardiology Reviews CRP Pro-inflammatory Signalling in Atherosclerosis: Myth or Reality?
Current Signal Transduction Therapy Is Age of 80 Years a Threshold for Carotid Revascularization?
Current Cardiology Reviews Consequences of Elevated Homocysteine During Embryonic Development and Possible Modes of Action
Current Pharmaceutical Design Statin Use in Aortic Aneurismal Disease to Prevent Progression and Cardiovascular Events: Review of Experimental and Clinical Data
Current Vascular Pharmacology Secondary Prevention of Ischemic Stroke
Current Drug Targets Biodegradable and Bioabsorbable Stents
Current Pharmaceutical Design Radiolabeled Iron Oxide Nanoparticles As Dual-Modality SPECT/MRI and PET/MRI Agents
Current Topics in Medicinal Chemistry Emerging Anti-inflammatory Therapies for Atherosclerosis
Current Pharmaceutical Design Pleiotropic Beneficial Effects of Epigallocatechin Gallate, Quercetin and Delphinidin on Cardiovascular Diseases Associated with Endothelial Dysfunction
Cardiovascular & Hematological Agents in Medicinal Chemistry Hypertension in China: Past, Present, and Future
Current Hypertension Reviews MicroRNA-mediated Regulation of Angiogenesis
Current Angiogenesis (Discontinued) Taking Risk Prediction to the Next Level. Advances in Biomarker Research for Atherosclerosis
Current Pharmaceutical Design Remodeling of the Myocardium and Potential Targets in the Collagen Degradation and Synthesis Pathways
Current Drug Targets - Cardiovascular & Hematological Disorders Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Current Pharmaceutical Design